Generalize Beyond the Lens: Deep Magnification Adaptation in Breast Cancer Histopathology

Read full text
Authors: K. A. Shahriar, Maruf Ahmed, Md. Sakib Abrar Hossain, Muhammad E. H. Chowdhury, Enamul H. Bhuiyan
Cited by: 1
References: 51

Abstract

Cross-magnification variability poses a critical challenge in deploying AI models for digital pathology, as classifiers trained at a single resolution often fail to generalize across heterogeneous imaging conditions. This study systematically investigates the effects of magnification domain shifts on breast histopathology classification by combining handcrafted machine-learning features, modern deep architectures, and progressive domain adaptation strategies. Although handcrafted models performed well in the domain, they degraded sharply under cross-magnification transfer, and shallow alignment methods such as CORAL and MMD yielded only marginal improvements. In contrast, deep transformer and convolutional backbones demonstrated greater robustness through hierarchical, scale-tolerant feature learning. Adversarial domain adaptation with DANN yielded the most consistent cross-magnification generalization (AUC = 0.975) and preserved malignant recall, a critical clinical requirement. Gradient reversal strength experiments revealed that moderate $$\lambda$$ values (0.5–0.8) yield an optimal balance between domain invariance and diagnostic discrimination. Grad-CAM and t-SNE confirmed that adapted models focused on biologically meaningful patterns and maintained coherent feature geometry across magnifications. Overall, this work highlights deep adversarial adaptation as an effective and interpretable solution for magnification-agnostic, clinically transferable computational pathology.

Fields of Study & Subjects

AI in cancer detection COVID-19 diagnosis using AI Medical Imaging and Analysis

Publication details

Journal / source
International Journal of Computational Intelligence Systems
Publisher
Springer Science and Business Media LLC
Volume
19
Issue
1
Publication date
4 April 2026
Language
EN